---
title: Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute
  lymphoblastic leukemia
date: '2024-09-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39316719/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240925194758&v=2.18.0.post9+e462414
source: Blood
description: Oncogenes can be activated in cis through multiple mechanisms including
  enhancer hijacking events and noncoding mutations that create enhancers or promoters
  de novo. These paradigms have helped parse somatic variation of noncoding cancer
  genomes, thereby providing a rationale to identify noncanonical mechanisms of gene
  activation. Here we describe a novel mechanism of oncogene activation whereby focal
  copy number loss of an intronic element within the FTO gene leads to aberrant expression
  ...
disable_comments: true
---
Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo. These paradigms have helped parse somatic variation of noncoding cancer genomes, thereby providing a rationale to identify noncanonical mechanisms of gene activation. Here we describe a novel mechanism of oncogene activation whereby focal copy number loss of an intronic element within the FTO gene leads to aberrant expression ...